TurboFectin 8.0 Transfection Reagent (1 mL in 1 vial)

1 review Add Review

SKU
TF81001
TurboFectin Transfection Reagent (1 mL in 1 vial)
  $530.00
In Stock*
Specifications
Specifications
Product Data
Components One (1) Vial TurboFectin Transfection Reagent (1.05 mL) 1 TurboFectin Application Guide
Features
  • Wide cell spectrum: valided on >100 cell lines and primary cells, view list
  • Very low cell toxicity
  • Simplified use: compatible with serum and antibiotics in the media
Quality Control Each batch of TurboFectin Transfection Reagent has been tested and yields at least 8 ng of luciferase per 35 mm well after transfection into NIH3T3 cells. TurboFectin reagent is supplied in ethanol to ensure sterility
Stability The transfection reagent is stable for one (1) year from date of shipping when stored at +4°C.
Storage Upon receipt, please store the TurboFectin Transfection Reagent at +4°C.
Type Transfection Reagent
Shipping Ambient
Description TurboFectin Transfection Reagent (1 mL in 1 vial)
Reviews (1)
4/5
Based on 1 review
0 votes
5 (0%)
1 vote
4 (100%)
0 votes
3 (0%)
0 votes
2 (0%)
0 votes
1 (0%)
Loading Reviews
Review image
Documents

file-alt Citations

Unravelling resistance mechanisms of oncolytic viruses in glioblastoma
Deconinck, Dierckx, Smet et al
bioRxiv (2026)
AI Summary: OriGene’s TurboFectin 8.0 (#TF81001) was used as the transfection reagent to generate virus-like particles in HEK293T cells, facilitating genetic manipulation essential for studying resistance mechanisms to oncolytic viruses in glioblastoma.
Snippet: Virus-like particles (VLPs) were generated in HEK293T cells via co-transfection of pBS‑CMV‑gagpol (RRID: Addgene_35614), pCMV‑MMLVgag‑3xNES‑Cas9 (RRID: Addgene_181752), pCMV‑VSV‑G (RRID: Addgene_8454), and the pU6‑sgRNA plasmid using an MLV‑based production system30 . HEK293T cells were plated in T150 flasks and transfected at 70–80% confluence using TurboFectin 8.0 (Origene, #TF81001)
Spindle Assembly Checkpoint Competency Determines Sensitivity to KIF18A Inhibition in Small-Cell Lung Cancer
Tabe, Kumar, Huang et al
bioRxiv (2026)
AI Summary: OriGene’s TurboFectin 8.0 (TF81001) was used for transfecting plasmids into cells to generate fluorescently labeled cell lines for live-cell imaging in this study.
Snippet: pHIV-H2B-eGFP (91776, 134 Addgene) or pHIV-H2B-mRFP (18982, Addgene) using TurboFectin 8.0 (TF81001, OriGene). 135 Viral supernatants were collected and used to infect target cells in the presence of polybrene (2 136 μg/mL)
ATP-Red enables single-cell bioenergetic phenotyping by flow cytometry
Marin, Singh, Fuchs et al
Cell Rep Methods (2026)
AI Summary: OriGene's TurboFectin 8.0 Transfection Reagent (SKU TF81001) was used in this study to facilitate the transfection of cells, enabling the evaluation of ATP-Red as a single-cell bioenergetic phenotyping tool by flow cytometry.
Snippet: Trypan blue, 0.04% Thermo Fisher Scientific Cat#15250061 0.25% trypsin-EDTA Gibco Cat#25200-056 TurboFectin 8.0 Transfection Reagent OriGene SKU TF81001
Hepatobiliary Progenitor-like Reprogramming in Liver Metastases
Sharma, Takahashi, Cao et al
bioRxiv (2026)
AI Summary: OriGene's Turbofectin 8.0 (TF81001) was used for efficient transduction of cells with lentiviral vectors, facilitating genetic manipulation essential for investigating hepatobiliary progenitor-like reprogramming in liver metastases.
Snippet: pCMV-VSV-G (Addgene #8454), and the transfer vectors pHIV-H2B-eGFP (Addgene #91776) or pHIV-H2B-mRFP (Addgene #18982). Transductions were performed using Turbofectin 8.0 (OriGene, TF81001). Viral supernatants were harvested at 48 and 72 hours post-transfection, filtered, pooled, and stored at -80°C
Localized actin cortex perturbation generates cell-scale membrane tension gradients
Panda, Fischer‐Friedrich
bioRxiv (2026)
AI Summary: OriGene's Turbofectin 8.0 (#TF81001) was used for lipofection to generate the transgenic HeLa cell line, enabling the study of membrane tension gradients in response to localized actin cortex perturbation.
Snippet: ng opto-RhoA, geneticin was added to the medium at a concentration of 0.4 mg/mL. Cell culture flasks were maintained at 37°C in a 5% CO2 environment. Cells were passaged every 2 − 3 day when they reached 60-80% confluency. The transgenic HeLa cell line was generated through lipofection using Turbofectin 8.0 (#TF81001, OriGene) according to the manufacturer’
APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer
Zhou, Wang, Du et al
Front Immunol (2026) 17, 1646920 DOI: 10.3389/fimmu.2026.1646920
AI Summary: OriGene products, specifically the negative control (TR30023) and transfection reagent (TF81001), were used for transfecting endometrial cancer cells in experiments assessing the functional roles of APO genes in this study.
Snippet: ), and the corresponding control (negative control;TR30023;OriGene) were transfected with reagents (TF81001;OriGene) for 12 h. The culture was then continued with a
Showing 1-6 of 82 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products